Assay§ | LFD+VEH | LFD+NDEA | HFD+VEH | HFD+NDEA | F-Ratio | P-Value |
---|
Serum ALT (U/L) | 17.3 ± 0.9 | 23.8 ± 3.9 | 30.6 ± 1.8** | 33.5 ± 2.1** | 10.08 | < 0.0001 |
Nile Red (RFU/μg) | 111.0 ± 2.6 | 128.3 ± 15.0 | 122.7 ± 6.1 | 147.9 ± 6.1* | 2.77 | 0.06 |
Cholesterol (ng/mg) | 360.5 ± 20.2 | 340.1 ± 33.9 | 435.4 ± 21.9 | 458.4 ± 19.7* | 5.02 | 0.011 |
Triglycerides (μg/mg) | 11.2 ± 1.5 | 10.8 ± 2.0 | 17.1 ± 0.8* | 21.0 ± 1.4** | 10.3 | 0.0003 |
- §ALT = alanine transaminase, Nile Red, cholesterol, and tryglyceride levels were measured in liver tissue. RFU/μg = relative fluorescence units; Nile red, cholesterol and triglyceride measurements are relative to liver. Inter-group comparisons were made using ANOVA tests. For all measurements, df = 3/36. Significant differences relative to the LFD control group were demonstrated using the Dunnett's post-hoc multiple comparison test (*P < 0.05; **P < 0.01; ***P < 0.001).